Is the ASCVD (Atherosclerotic Cardiovascular Disease) risk estimator plus from the American College of Cardiology applicable to Indian people?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ASCVD Risk Estimator Plus Is Not Validated for Indian Populations and Likely Underestimates Risk

The ASCVD Risk Estimator Plus from the American College of Cardiology is not validated for Indian populations and likely underestimates cardiovascular risk in this group. 1 The tool was specifically developed and validated only for non-Hispanic Whites and African Americans, making it unsuitable for accurate risk assessment in Indian people without modification.

Limitations of ASCVD Risk Estimator in South Asians

Validation Issues

  • The ACC/AHA Pooled Cohort Equations were derived from and validated in White and Black U.S. adults only 1
  • None of the traditional risk calculators, including the ASCVD Risk Estimator Plus, have been derived from or prospectively validated in South Asian populations 1
  • The 2013 ACC/AHA guidelines explicitly state that the equations are validated only for non-Hispanic African Americans and non-Hispanic Whites aged 40-79 years 1

Risk Underestimation

  • The ASCVD Risk Estimator Plus systematically underestimates cardiovascular risk in South Asians 1
  • South Asians have higher rates of ASCVD compared to other racial/ethnic groups, with higher proportionate mortality from ischemic heart disease 2
  • South Asians tend to have multiple risk factors at younger ages, but age is a driving factor in most risk scores, leading to artificially lower scores 1

Alternative Approaches for Indian Patients

Recommended Modifications

  • Some experts advocate applying a correction factor of 1.4 to 1.5 to the calculated risk score to account for the higher risk in South Asians 1
  • The 2013 ACC/AHA guidelines suggest that "use of the sex-specific Pooled Cohort Equations for non-Hispanic Whites may be considered" for other populations, including South Asians 1
  • Risk estimation should be adjusted upward due to the known underestimation of risk in South Asians 2

Alternative Risk Assessment Tools

  • The UK QRISK2 algorithm has been derived and validated in 2.3 million people including South Asians and counts South Asian ethnicity as an additional risk factor 1
  • ETHRISK is another web-based risk calculator validated in South Asians 1
  • Consider CAC scoring for further risk stratification, especially in those with borderline (5% to <7.5%) or intermediate (≥7.5% to <20%) 10-year risk 2

Unique Cardiovascular Risk Profile of South Asians

Anatomical and Physiological Differences

  • South Asians have smaller coronary artery luminal diameters 2
  • South Asians have a higher coronary artery calcium (CAC) burden, with Asian Indian race being an independent predictor of CAC severity 2
  • South Asians have higher rates of non-calcified plaque which may not be detected by CAC scoring 2

Risk Factor Prevalence

  • Higher prevalence of diabetes, dyslipidemia, and metabolic syndrome in South Asians 2
  • Metabolic syndrome is seen with lower waist circumference thresholds than in whites 1
  • Studies in Punjab, India show that many patients with hypertension and diabetes fall into intermediate (37.8%) or high (27.9%) ASCVD risk categories 3

Clinical Approach for Indian Patients

  1. Use the ASCVD Risk Estimator Plus with caution, recognizing its limitations in South Asians
  2. Consider applying a correction factor of 1.4-1.5 to the calculated risk score
  3. Utilize UK QRISK2 if available as it's validated in South Asians
  4. Consider additional risk stratification with CAC scoring, especially for:
    • Patients with borderline or intermediate risk
    • Those with family history of premature ASCVD
    • Patients over 60 years of age
  5. Pay special attention to metabolic risk factors that are more prevalent in South Asians
  6. Consider lifetime risk estimation for adults 20-39 years or those 40-59 years with <7.5% 10-year risk

By recognizing the limitations of the ASCVD Risk Estimator Plus in Indian populations and implementing appropriate modifications or alternative tools, clinicians can more accurately assess cardiovascular risk and implement appropriate preventive strategies for this high-risk group.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiovascular Risk Assessment in Indian Population

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.